Lucy Scientific Discovery IncOver The Counter Market:LSDIF
- LAST PRICE0.0500
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close--- / 0.0500
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Lucy Scientific Discovery Inc | 88.2K | 0.0x | --- |
Oncology Pharma Inc | 7.7K | 0.0x | --- |
Gelstat Corp | 210.0K | -0.1x | --- |
Earth Life Sciences Inc | 100.0K | -0.2x | --- |
PharmaRoth Labs Inc | 390.0 | 0.0x | --- |
Neutra Corp | 2.9K | 0.0x | --- |
Company Information
Lucy Scientific Discovery Inc. is an early stage psychotropics contract manufacturing company. The Company is engaged in researching, developing, and manufacturing psychotropic drugs. The Company is a manufacturer of controlled compounds dedicated to advancing the frontiers of mind science and facilitating the development of psychotropic and psychedelic treatment therapies. It is focused on developing therapies for patients in need, and through its lead candidate SANA-013, dedicated to advancing the understanding and applications of psychedelic medicine, improving mental health outcomes, and enhancing well-being for individuals worldwide. The Company is engaged in the production of a variety of natural, synthetic, and biosynthetic products to meet the needs of the psychotropics-based medicines market. Its products are in the form of raw materials, crude extracts, targeted formulations, single molecule fractions, and white- and private-label products.
Contact Information
- Headquarters
- 301-1321 Blanshard StreetVICTORIA, BC, Canada V8W 0B6
- Phone
- 778-410-5195
- Fax
- ---
Executives
- Executive Chairman of the Board, Chief Executive Officer
- Richard Nanula
- Chief Scientific Officer
- Assad Kazeminy
- Independent Director
- Paul Abramowitz
- Independent Director
- Brittany Kaiser
- Independent Director
- Charles Nemeroff
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $88.2K |
|---|---|
Revenue (TTM) | $16.7K |
Shares Outstanding | 1.8M |
Lucy Scientific Discovery Inc does not pay a dividend. | |
Beta | --- |
EPS | $-6.34 |
Book Value | $2.68 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 5.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -47,783.98% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
